Skip to content

Teriparatide (PTH 1-34) studies: 484 papers with results

Page 6 of 10

  1. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

    Senn C · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014

    Observational study · 2 results

  2. Short-term daily teriparatide improve postoperative functional outcome and fracture healing in unstable intertrochanteric fractures.

    Kim SJ · Injury · 2019

    Observational study · 4 results

  3. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.

    Iwata A · BMC musculoskeletal disorders · 2017

    Observational study · 6 results

  4. The Effect of Postoperative Use of Teriparatide Reducing Screw Loosening in Osteoporotic Patients.

    Kim JW · Journal of Korean Neurosurgical Society · 2018

    Observational study · 6 results

  5. Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity.

    Yagi M · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016

    Observational study · 7 results

  6. Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture.

    Park JH · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014

    Observational study · 6 results

  7. Weekly Teriparatide Administration and Preoperative Anterior Slippage of the Cranial Vertebra Next to Fusion Segment < 2 mm Promote Osseous Union After Posterior Lumbar Interbody Fusion.

    Ushirozako H · Spine · 2019

    Observational study · 3 results

  8. Comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty.

    Su CH · Journal of spinal disorders & techniques · 2013

    Observational study · 3 results

  9. Effects of teriparatide versus percutaneous vertebroplasty on pain relief, quality of life and cost-effectiveness in postmenopausal females with acute osteoporotic vertebral compression fracture: A prospective cohort study.

    Ma Y · Bone · 2020

    Observational study · 7 results

  10. Teriparatide treatment increases Hounsfield units in the lumbar spine out of proportion to DEXA changes.

    Mikula AL · Journal of neurosurgery. Spine · 2020

    Observational study · 4 results

  11. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.

    Anastasilakis AD · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014

    Observational study · 1 result

  12. Adherence and persistence in patients with severe osteoporosis treated with teriparatide.

    Ziller V · Current medical research and opinion · 2010

    Observational study · 4 results

  13. Effect of Teriparatide on Subsequent Vertebral Fractures after Instrumented Fusion Surgery for Osteoporotic Vertebral Fractures with Neurological Deficits.

    Maruo K · Asian spine journal · 2019

    Observational study · 2 results

  14. Teriparatide Treatment in Elderly Patients With Sacral Insufficiency Fracture.

    Yoo JI · The Journal of clinical endocrinology and metabolism · 2017

    Observational study · 2 results

  15. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study.

    Nishikawa A · Clinical interventions in aging · 2016

    Observational study · 6 results

  16. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis.

    Hong N · Clinical endocrinology · 2018

    Observational study · 3 results

  17. Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.

    Leder BZ · The Journal of clinical endocrinology and metabolism · 2009

    Observational study · 14 results

  18. More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery.

    Ohtori S · Asian spine journal · 2015

    Observational study · 6 results

  19. Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis.

    Inoue G · Journal of neurosurgery. Spine · 2014

    Observational study · 2 results

  20. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.

    Boonen S · Journal of the American Geriatrics Society · 2006

    Observational study · 12 results

  21. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.

    Hansen S · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013

    Observational study · 9 results

  22. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

    Winer KK · The Journal of pediatrics · 2018

    Observational study · 11 results

  23. Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH1-34): A Pilot Study.

    Cejka D · Kidney & blood pressure research · 2010

    Observational study · 6 results

  24. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.

    Chiang CY · Bone · 2013

    Observational study · 5 results

  25. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis.

    Marcus R · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2003

    Observational study · 8 results

  26. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

    Langdahl BL · Calcified tissue international · 2009

    Observational study · 7 results

  27. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.

    Miyakoshi N · Journal of bone and mineral metabolism · 2015

    Observational study · 6 results

  28. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.

    Kim KM · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014

    Observational study · 4 results

  29. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.

    Yeh WL · BMC musculoskeletal disorders · 2017

    Observational study · 4 results

  30. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.

    Kakehashi H · International journal of oral and maxillofacial surgery · 2015

    Case report or series · 3 results

  31. Teriparatide in Fracture Non-Unions.

    Coppola C · Translational medicine @ UniSa · 2015

    Case report or series · 2 results

  32. Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases.

    Rubery PT · Journal of spinal disorders & techniques · 2010

    Case report or series · 2 results

  33. PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

    Theman TA · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2009

    Case report or series · 10 results

  34. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.

    Linglart A · The Journal of clinical endocrinology and metabolism · 2011

    Case report or series · 1 result

  35. Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases.

    Lee YK · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012

    Case report or series · 2 results

  36. Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

    Subbiah V · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2010

    Case report or series · 1 result

  37. Adult hypophosphatasia treated with teriparatide.

    Whyte MP · The Journal of clinical endocrinology and metabolism · 2007

    Case report or series · 6 results

  38. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.

    Carvalho NN · The Journal of clinical endocrinology and metabolism · 2011

    Case report or series · 3 results

  39. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.

    Lee JJ · Head & neck · 2011

    Case report or series · 3 results

  40. Treatment of adult hypophosphatasia with teriparatide.

    Camacho PM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2008

    Case report or series · 10 results

  41. Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report.

    Doshi KB · Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases · 2009

    Case report or series · 8 results

  42. Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report.

    Palcu P · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2015

    Case report or series · 9 results

  43. Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.

    Vahle JL · Toxicologic pathology · 2004

    Animal study (in vivo) · rat · 5 results

  44. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.

    Lane NE · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1996

    Animal study (in vivo) · rat · 12 results

  45. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

    Vahle JL · Toxicologic pathology · 2002

    Animal study (in vivo) · rat · 13 results

  46. Effect of daily parathyroid hormone (1-34) on lumbar fusion in a rat model.

    Lawrence JP · The spine journal : official journal of the North American Spine Society · 2006

    Animal study (in vivo) · sprague-dawley rats · 2 results

  47. Effect of intermittent teriparatide (PTH 1-34) on the alveolar healing process in orchiectomized rats.

    de Oliveira D · Clinical oral investigations · 2019

    Animal study (in vivo) · rat · 8 results

  48. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures.

    Tägil M · Bone · 2010

    Animal study (in vivo) · rat · 9 results

  49. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model.

    O'Loughlin PF · Spine · 2009

    Animal study (in vivo) · new zealand white rabbits · 7 results

  50. Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study.

    Skripitz R · The Journal of bone and joint surgery. British volume · 2000

    Animal study (in vivo) · rat · 5 results

How PepBank reports evidence